华人健康
(301408)
| 流通市值：33.77亿 | | | 总市值：59.00亿 |
| 流通股本：2.29亿 | | | 总股本：4.00亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,824,690,091.29 | 1,420,983,890.57 | 5,486,683,545.91 | 3,892,464,110.99 |
| 营业总成本 | 2,625,439,993.61 | 1,306,494,171.94 | 5,115,071,415.63 | 3,664,095,124.7 |
| 其他经营收益 | | | | |
| 营业利润 | 201,966,310.38 | 111,772,319.62 | 300,182,917.69 | 226,093,797.7 |
| 利润总额 | 200,300,688.39 | 110,790,242.3 | 294,390,720.4 | 222,350,732.8 |
| 净利润 | 148,404,786.67 | 86,083,860.45 | 213,866,632.27 | 171,391,855.81 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 1,400,217.49 | 1,563,598.63 |
| 综合收益总额 | 148,404,786.67 | 86,083,860.45 | 215,266,849.76 | 172,955,454.44 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,883,609,566.26 | 2,982,310,973.37 | 2,912,921,351.49 | 2,708,150,834.44 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,584,651,343.07 | 2,568,781,092.73 | 2,575,411,789.98 | 2,660,810,775.54 |
| 资产总计 | 5,468,260,909.33 | 5,551,092,066.1 | 5,488,333,141.47 | 5,368,961,609.98 |
| 流动负债: | | | | |
| 流动负债合计 | 2,669,267,621.07 | 2,648,791,813.92 | 2,685,555,698.23 | 2,494,677,147.88 |
| 非流动负债: | | | | |
| 非流动负债合计 | 625,193,860.14 | 658,552,578.94 | 639,673,630.45 | 714,201,763.6 |
| 负债合计 | 3,294,461,481.21 | 3,307,344,392.86 | 3,325,229,328.68 | 3,208,878,911.48 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,118,892,308.38 | 2,176,321,049.16 | 2,096,977,526.88 | 2,096,021,280.8 |
| 股东权益合计 | 2,173,799,428.12 | 2,243,747,673.24 | 2,163,103,812.79 | 2,160,082,698.5 |
| 负债和股东权益合计 | 5,468,260,909.33 | 5,551,092,066.1 | 5,488,333,141.47 | 5,368,961,609.98 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,073,766,239.18 | 1,479,584,025.26 | 5,407,080,653.17 | 3,942,292,569.8 |
| 经营活动现金流出小计 | 2,664,123,623.01 | 1,175,035,905.76 | 4,569,899,484.68 | 3,352,315,426.82 |
| 经营活动产生的现金流量净额 | 409,642,616.17 | 304,548,119.5 | 837,181,168.49 | 589,977,142.98 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 844,556,694.36 | 251,595,886.76 | 1,809,595,623.03 | 1,513,133,654.42 |
| 投资活动现金流出小计 | 907,428,678.67 | 451,959,010.27 | 2,456,742,565.83 | 2,164,027,213.18 |
| 投资活动产生的现金流量净额 | -62,871,984.31 | -200,363,123.51 | -647,146,942.8 | -650,893,558.76 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 463,055,847.31 | 63,083,621.06 | 734,601,065 | 514,448,065 |
| 筹资活动现金流出小计 | 773,032,527.09 | 215,781,703.52 | 979,119,948.28 | 568,710,193.84 |
| 筹资活动产生的现金流量净额 | -309,976,679.78 | -152,698,082.46 | -244,518,883.28 | -54,262,128.84 |
| 汇率变动对现金及现金等价物的影响 | -294,450.8 | -140,740.23 | -133,423.32 | -58,249.65 |
| 现金及现金等价物净增加额 | 36,499,501.28 | -48,653,826.7 | -54,618,080.91 | -115,236,794.27 |
| 期末现金及现金等价物余额 | 304,761,483.04 | 219,608,155.06 | 268,261,981.76 | 207,643,268.4 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 36,499,501.28 | - | -54,618,080.91 | - |